WHO ICTRP trial
A randomized, controlled, multi-center study evaluating combined operation…
ChiCTR-PRC-08000244 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-PRC-08000244 |
|---|---|
| Public title | A randomized, controlled, multi-center study evaluating combined operation modality vs imatinib alone (COMVIA) in patients with recurrent/metastatic c-kit positive gastrointestinal stromal tumor |
| Scientific title | A randomized, controlled, multi-center study evaluating combined operation modality vs imatinib alone (COMVIA) in patients with recurrent/metastatic c-kit positive gastrointestinal stromal tumor |
| Primary sponsor | Cancer hospital affiliated to Fudan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Prevention |
| Phase | Post-market |
| Countries | China |
| Conditions | gastrointestinal stromal tumor(GIST) |
| Interventions | Arm A:imatinib + surgery;Arm B:imatinib |
| Registration date | Dec 21, 2008 |
| Target size | Arm A:105;Arm B:105 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: